Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
The aim of this work was to study at what extent mixtures of drug substances and oppositely charged surfactants form catanionic aggregates and to apply these as a means of obtaining prolonged drug release from a gel. The properties of traditional catanionic mixtures are relatively well known, but only recently we found that not only traditional surfactants form these mixtures, but also structurally more complex surface active drug compounds. In this study, several different compositions of catanionic mixtures were studied visually, by cryogenic transmission electron microscopy (cryo-TEM) and rheologically using a Bohlin VOR Rheometer. Some of the catanionic vesicle and micelle phases were incorporated in and released from gels using the USP paddle method. The drug compounds investigated were lidocaine, ibuprofen, naproxen, alprenolol, propranolol, and orphenadrine. Of the six drug molecules used in this study, five, both positively and negatively charged, were capable of forming catanionic vesicles and/or micelles with oppositely charged surfactants. The drug release studies show that catanionic drug surfactant mixtures are beneficial for obtaining prolonged release from gels, as the drug release using catanionic vesicles and micelles was prolonged between 10 and 100 times compared to the release of pure drug substance from the gel.
Bramer
Tobias
T
Department of Pharmacy, Uppsala University, Box 580, SE-751 23 Uppsala, Sweden.
Dew
Noel
N
Edsman
Katarina
K
D000838:Anions / Q000737:chemistry; D002412:Cations / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D020285:Cryoelectron Microscopy; D003692:Delayed-Action Preparations; D004058:Diffusion; D005782:Gels / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D007052:Ibuprofen / Q000737:chemistry; D007700:Kinetics; D008012:Lidocaine / Q000737:chemistry; D008823:Micelles; D009966:Orphenadrine / Q000737:chemistry; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012212:Rheology; D012967:Sodium Dodecyl Sulfate / Q000737:chemistry; D012995:Solubility; D013501:Surface-Active Agents / Q000737:chemistry*
D000838:Anions; D002412:Cations; D003692:Delayed-Action Preparations; D005782:Gels; D008823:Micelles; D004364:Pharmaceutical Preparations; D013501:Surface-Active Agents; D012967:Sodium Dodecyl Sulfate; D008012:Lidocaine; D009966:Orphenadrine; D007052:Ibuprofen